ClinicalTrialsFinder

Juvenile Nasopharyngeal Angiofibroma Clinical Trials in Moscow

1 recruitingMoscow, Russia

Showing 1–1 of 1 trials

Recruiting
Phase 3

Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)

Juvenile Nasopharyngeal Angiofibroma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology117 enrolled1 locationNCT05549167